Physician

Regina Feliu, MD

According to 2025 Medicare claims, Regina Feliu, MD (NPI: 1225068323) practices family practice in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is CRC MANAGEMENT CORP (NPI: 1407690027) and primary practice location at 33169-4518.

Feliu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 15 traditional Medicare patients, billed 2,108 HCPCS/CPT codes, and received $4,423,657 in Medicare payments. The top billing code was Q4250 (Amnioamp-mp, per square centimeter). Part D data shows 15,119 prescription claims across 438 beneficiaries totaling $580,360 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 183 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.4M2024 Medicare payment: $4,423,657 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024152,108$4,423,657

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$434K$867K2015 Drug cost: $404,201 (USD; Tot_Drug_Cst)2016 Drug cost: $627,052 (USD; Tot_Drug_Cst)2017 Drug cost: $867,211 (USD; Tot_Drug_Cst)2018 Drug cost: $717,096 (USD; Tot_Drug_Cst)2019 Drug cost: $659,286 (USD; Tot_Drug_Cst)2020 Drug cost: $761,689 (USD; Tot_Drug_Cst)2021 Drug cost: $751,329 (USD; Tot_Drug_Cst)2022 Drug cost: $695,114 (USD; Tot_Drug_Cst)2023 Drug cost: $664,203 (USD; Tot_Drug_Cst)2024 Drug cost: $580,360 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563216,882$404,201
201672623,719$627,052
201784224,397$867,211
201867621,056$717,096
201958920,051$659,286
202054621,750$761,689
202156120,366$751,329
202246417,498$695,114
202341515,985$664,203
202443815,119$580,360

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$184K$369K2015 Medicare payment: $335 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $62,827 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $368,911 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$335
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192222$62,827
2020N/RN/RN/R
2021N/RN/RN/R
202292183$368,911
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q4250Amnioamp-mp, per square centimeter152,016$2,183
15273Skin substitute graft to wound 100.0 sq cm or more of trunk, arms, or legs, 100.0 sq cm or 1% body area for infants and children, or less1590$257

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban1514,535$85,562
ProliaDenosumab203,600$36,945
Solifenacin SuccinateSolifenacin Succinate635,050$32,485
JanuviaSitagliptin Phosphate461,620$29,388
PradaxaDabigatran Etexilate Mesylate1243,750$23,717

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Regina Feliu, MD?

Tedicare shows public-source Medicare data for Regina Feliu, MD (NPI 1225068323), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Regina Feliu, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Regina Feliu, MD?

Regina Feliu, MD is linked to CRC MANAGEMENT CORP (billing NPI 1407690027) in the available physician profile data.

Does Regina Feliu, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.